Learn, Analyse & Invest
only with
only with
+91
Download Orca
Aurobindo Pharma Ltd.
Aurobindo Pharma
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Mid-cap - With a market cap of ₹681.08 Cr.
Financial Strength
Weak
Ratios Analysis
Balance Sheet
Results Analysis
Cash Flow
Profit Loss
Key Metrics
Market Capitalisation
₹ 68107.7 Cr.
Enterprise Value
₹ 72288 Cr.
Shares Outstanding
58.08 Cr.
Dividend Yield
0%
Face Value
₹ 1
Book Value
₹ 369.16
TTM EPS
34.79 Cr.
TTM-PE
33.7
Latest Equity
58.08
Latest Reserve
₹ 21383
Peers Comparison
| Stocks | CMP (₹) | Mark. Cap Size | P/E | P/B | EPS | ROE |
|---|---|---|---|---|---|---|
| Abbott India | Loading... | Mid-cap | 46.17 | 15.53 | 665.62 | 35.98 |
| Ipca Laboratories | Loading... | Mid-cap | 51.63 | 5.48 | 29.08 | 11.86 |
| Glenmark Pharma | Loading... | Mid-cap | 41.5 | 4.92 | 37.11 | 12.56 |
| Glaxosmithkline Phar | Loading... | Mid-cap | 52.55 | 24.79 | 54.76 | 49.43 |
| Ajanta Pharma | Loading... | Mid-cap | 35.53 | 8.64 | 73.69 | 25.06 |
